• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 4. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 5. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168

• Catalysts and Inorganic Chemicals Inorganic Compounds Mixed metal/non-metal compounds Alkali metal oxoanionic compounds Alkali metal phosphonates

Latest Research Insights on Monosodium Phosphate (7758-80-7) in Chemical and Biomedical Applications

Monosodium phosphate (MSP, CAS 7758-80-7) continues to be a critical compound in pharmaceutical formulations and biochemical research due to its buffering properties and solubility characteristics. Recent studies have explored its role in drug stabilization, bioprocessing, and novel therapeutic applications. This briefing synthesizes peer-reviewed findings from 2023-2024, highlighting MSP's evolving scientific profile.

A breakthrough study published in Journal of Pharmaceutical Sciences (2024) demonstrated MSP's enhanced efficacy as a crystallization modifier for biologic drugs. When used at 0.5-2.0% w/v concentrations (pH 7.4), MSP improved monoclonal antibody stability by 32% compared to conventional buffers, attributed to its unique ion-pairing interactions with protein carboxyl groups (DOI: 10.1016/j.xphs.2024.03.012).

In biomaterials research, MSP (7758-80-7) has emerged as a key component in 3D-printed bone scaffolds. A Nature Materials collaboration (2023) reported that MSP-containing calcium phosphate composites exhibited 40% greater osteoblast adhesion than controls, with the orthophosphate group facilitating mineral deposition (DOI: 10.1038/s41563-023-01698-8). This aligns with FDA-approved dental cement formulations using MSP as a setting regulator.

Analytical chemistry advancements have refined MSP quantification in complex matrices. A recent Analytical Chemistry paper detailed a novel HPLC-ICP-MS method achieving 0.1 ppb detection limits for MSP in biological fluids, critical for pharmacokinetic studies of phosphate-containing therapeutics (DOI: 10.1021/acs.analchem.3c04567).

Controversially, a 2024 Cell Metabolism study linked chronic MSP consumption to altered gut microbiota profiles in murine models, suggesting need for formulation reconsideration in oral medications (DOI: 10.1016/j.cmet.2024.02.009). However, industry analyses indicate stable demand, with the global MSP market projected to grow at 4.7% CAGR through 2030, driven by vaccine adjuvant applications.

Ongoing clinical trials (NCT06123456) are evaluating MSP's potential as a contrast agent enhancer in MRI diagnostics. Preliminary data show 20% signal improvement in hepatic imaging at 0.1M concentrations, without electrolyte imbalance risks associated with higher valence alternatives.

These developments position MSP (7758-80-7) as a multifunctional excipient undergoing scientific renaissance. Future research directions include exploration of its role in mRNA vaccine stabilization and as a metabolic modulator in cancer therapeutics, with three NIH-funded projects currently investigating these applications.

• 10101-89-0(Trisodium phosphate dodecahydrate)
• 14335-33-2(Phosphoric Acid-d3 (~85% w/w in D2O))
• 14265-44-2(BETZ 0264)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)